Article

More Than One-Third of Patients Hospitalized for Asthma Exacerbations are Smokers

Author(s):

Although 35% of US patients hospitalized for an asthma exacerbation were current smokers, only 55% of current smokers received a smoking cessation intervention during their hospital stay.

adults, asthma, cigarette smoking, exacerbation, health insurance, hospitalization, intervention, multicenter, multivariate model, observational, prevalence, pulmonology, secondary analysis, smoking cessation, tobacco use, internal medicine, public health, hospital medicine, hospital care, smoking prevention

To determine the prevalence of cigarette smoking in US adults hospitalized for asthma, and to learn more about how many of them received in-patient smoking cessation intervention, researchers at Harvard University and Massachusetts General Hospital analyzed the results of a previous multicenter observational study. That study included 597 U.S. adults admitted to the hospital for an asthma exacerbation in 2012 or 2013. The researchers published the results of their secondary analysis in the July/August issue of Allergy and Asthma Proceedings.

In the cohort analyzed, 215 patients, or 36%, were current smokers. Patients with private health insurance were far less likely to be among this group than those with public or no health insurance. Patients who had been evaluated by an asthma specialist in the last 12 months, as well as users of inhaled corticosteroids, were also less likely to be current smokers.

During their hospital stay, only 55% of current smokers received any smoking cessation intervention. Current smokers who had public health insurance or no health insurance were less likely to receive such an intervention than those with private health insurance.

According to the researchers, these finding revealed a persistently high prevalence of smoking among U.S. patients hospitalized for asthma exacerbations. These findings also found that opportunities to provide these patients with smoking cessation interventions during their hospital stay, when they may be strongly motivated to make positive health changes, were underutilized. The study also suggests that in-patient smoking cessation interventions should focus on patients with public health insurance or no health insurance, for whom such interventions may be less accessible.

In a similar multicenter study back in 1999 and 2000, the prevalence of smoking among U.S. patients admitted for asthma exacerbation was close to the new result: 35%. That study also showed that efforts to promote smoking cessation in these patients had been less than optimal.

Related Coverage:

Allergen Immunotherapy May Prevent Progression of Allergic Rhinitis to Asthma

Asthmatics with Elevated Eosophinol Levels Far More Likely To Require Hospital Admission

Smoking Impairs the Effectiveness of Inhaled Corticosteroids

Related Videos
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
Physician, Patient, and Partner Perspectives on AERD with Mitchell Grayson, MD, Rhonda Nelson, and Wayne Nelson
Monica Kraft, MD: Discussing Phase 3b Findings on Albuterol/Budesonide for Asthma
How Artificial Intelligence is Being Used in Lung Imaging, with Rachel Eddy, PhD
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
Discussing Use of Vaping Among Students, Conversations About Vaccines
© 2024 MJH Life Sciences

All rights reserved.